Company record · ATRA

Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc.'s interim chief financial officer on the record is Kevin G. Sarney, effective June 26, 2026, per the filing record.

Tracked changes

2026-06-26

Atara Biotherapeutics, Inc. names Kevin G. Sarney interim CFO

This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.